LMR Partners’s SomaLogic, Inc. Warrant SLGCW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-787,472
Closed -$94.5K 1394
2023
Q4
$94.5K Buy
787,472
+16,362
+2% +$2.33K ﹤0.01% 769
2023
Q3
$170K Buy
771,110
+34,913
+5% +$8.56K ﹤0.01% 646
2023
Q2
$184K Buy
736,197
+16,040
+2% +$5.78K ﹤0.01% 588
2023
Q1
$1.84M Buy
720,157
+2,300
+0.3% +$1.01K 0.03% 457
2022
Q4
$1.8M Buy
717,857
+144,280
+25% +$57.4K 0.03% 558
2022
Q3
$1.66M Buy
573,577
+223,842
+64% +$149K 0.03% 586
2022
Q2
$1.58M Buy
+349,735
New +$397K 0.03% 597
2022
Q1
Sell
-49,725
Closed -$579K 1388
2021
Q4
$579K Buy
49,725
+13,495
+37% +$51.6K 0.01% 864
2021
Q3
$449K Buy
+36,230
New +$112K 0.01% 820

Other funds holding SLGCW

LMR Partners's SLGCW Position: Q1 2024 in Review

LMR Partners sold out of SomaLogic, Inc. Warrant (SLGCW) in Q1 2024, closing a stake of 787,472 shares — an estimated $94.5K sold.

LMR Partners first reported a position in SLGCW in Q3 2021 and held it in 9 quarters. The position peaked at $1.84M in Q1 2023. 4 funds tracked by Wall St. Rank hold SLGCW as of Q1 2024.

  • LMR Partners reported no remaining SomaLogic, Inc. Warrant position as of Q1 2024 after selling out during the quarter.
  • LMR Partners sold 787,472 SomaLogic, Inc. Warrant shares in Q1 2024, an estimated $94.5K.
  • LMR Partners first reported a position in SomaLogic, Inc. Warrant in Q3 2021 and held it in 9 quarters.
  • LMR Partners's SomaLogic, Inc. Warrant position peaked at $1.84M in Q1 2023.
  • 4 funds tracked by Wall St. Rank held SomaLogic, Inc. Warrant as of Q1 2024.

Based on LMR Partners's 13F filing for Q1 2024, filed 15 May 2024.